Myrexis Competitors and Similar CompaniesClear all
Merrimack Pharmaceuticals's competitors and similar companies include Oncopeptides.
 Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. | ||
Founding Date | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 2763% decrease | Employees 80 |
Valuation ($) | Valuation ($) 223.7 m | Valuation ($) 42.4 m |
Financial | ||
Net income | Net income ($1.2m) (FY, 2023) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company